Click image to enlarge
The
V-PLEX platform offers analytically validated singleplex and multiplex assay kits. Developed under rigorous design control, V-PLEX kits provide accurate and reproducible results with consistency from lot to lot. The V-PLEX Cytokine Panel 1 (human) Kit includes ten biomarkers that are associated with the inflammatory response and immune system regulation (Table 1). The assays can be used for quantitative measurements in the sample types listed in the “Specifications” tab below and offer detection limits (LLODs and LLOQs) in the sub- to low pg/mL range.
| Analyte | LLOD | LLOQ | ULOQ | Dynamic Range | Unit |
|---|
| GM-CSF | 0.16 | 0.842 | 750 | 0.16 - 750 | pg/mL |
| IL-1α | 0.09 | 2.85 | 278 | 0.09 - 278 | pg/mL |
| IL-5 | 0.14 | 4.41 | 562 | 0.14 - 562 | pg/mL |
| IL-7 | 0.12 | 0.851 | 563 | 0.12 - 563 | pg/mL |
| IL-12/IL-23p40 | 0.33 | 1.32 | 2,250 | 0.33 - 2,250 | pg/mL |
| IL-15 | 0.15 | 0.774 | 525 | 0.15 - 525 | pg/mL |
| IL-16 | 2.83 | 19.1 | 1,870 | 2.83 - 1,870 | pg/mL |
| IL-17A | 0.31 | 3.19 | 3,650 | 0.31 - 3,650 | pg/mL |
| TNF-β | 0.08 | 0.465 | 458 | 0.08 - 458 | pg/mL |
| VEGF-A | 1.12 | 7.7 | 562 | 1.12 - 562 | pg/mL |
|
-
-
Specifications
-
Kit Contents
-
Documentation
-
References
|
Application(s)
|
|
Cytokines & Chemokines
,
Immunology/Inflammation
|
|
|
Analyte(s)
|
|
GM-CSF, IL-1α, IL-5, IL-7, IL-12/IL-23p40, IL-15, IL-16, IL-17A, TNF-β, VEGF-A
|
|
|
Species
|
|
Human
|
|
|
Instrument(s)
|
|
MESO SECTOR S 600MM
,
MESO QuickPlex SQ 120MM
,
MESO SECTOR S 600
,
MESO QuickPlex SQ 120
,
SECTOR Imager 6000
,
SECTOR Imager 2400
|
|
|
Plate Type
|
|
96-well
|
|
|
Sample Type
|
|
Serum, Plasma, Urine, Cell Culture Supernatant
|
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
|
Storage Statement(s)
|
|
Please refer to the product insert for the storage conditions of individual kit components.
|
|
|
Storage Condition
|
|
Multi-Component
|
|
|
Schedule B Code
|
|
3822.19.0000
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
|
2-8 °C
|
1 vial
(1 vial)
|
|
|
|
|
2-8 °C
|
1 vial
(75 μL)
|
|
|
|
|
2-8 °C
|
1 vial
(75 μL)
|
|
|
|
|
2-8 °C
|
1 vial
(75 μL)
|
|
|
|
|
2-8 °C
|
1 vial
(75 μL)
|
|
|
|
|
2-8 °C
|
1 vial
(75 μL)
|
|
|
|
|
2-8 °C
|
1 vial
(75 μL)
|
|
|
|
|
2-8 °C
|
1 vial
(75 μL)
|
|
|
|
|
2-8 °C
|
1 vial
(75 μL)
|
|
|
|
|
2-8 °C
|
1 vial
(75 μL)
|
|
|
|
|
2-8 °C
|
1 vial
(75 μL)
|
|
|
|
Cytokine Panel 1 (human) Plate
|
2-8 °C
|
1 each
(1 each)
|
|
|
|
Diluent Assembly 3 (includes Diluent 3 - 5 mL, and Diluent 43 - 10 mL)
|
≤-10 °C
|
1 each
|
|
|
|
|
RT
|
1 bottle
(50 mL)
|
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
|
2-8 °C
|
5 vial
(1 vial)
|
|
|
|
|
2-8 °C
|
1 vial
(375 μL)
|
|
|
|
|
2-8 °C
|
1 vial
(375 μL)
|
|
|
|
|
2-8 °C
|
1 vial
(375 μL)
|
|
|
|
|
2-8 °C
|
1 vial
(375 μL)
|
|
|
|
|
2-8 °C
|
1 vial
(375 μL)
|
|
|
|
|
2-8 °C
|
1 vial
(375 μL)
|
|
|
|
|
2-8 °C
|
1 vial
(375 μL)
|
|
|
|
|
2-8 °C
|
1 vial
(375 μL)
|
|
|
|
|
2-8 °C
|
1 vial
(375 μL)
|
|
|
|
|
2-8 °C
|
1 vial
(375 μL)
|
|
|
|
Cytokine Panel 1 (human) Plate
|
2-8 °C
|
5 each
(1 each)
|
|
|
|
Diluent Assembly 4 (includes Diluent 3 - 25 mL, and Diluent 43 - 50 mL)
|
≤-10 °C
|
1 each
|
|
|
|
|
RT
|
1 bottle
(50 mL)
|
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
|
2-8 °C
|
25 vial
(1 vial)
|
|
|
|
|
2-8 °C
|
5 vial
(375 μL)
|
|
|
|
|
2-8 °C
|
5 vial
(375 μL)
|
|
|
|
|
2-8 °C
|
5 vial
(375 μL)
|
|
|
|
|
2-8 °C
|
5 vial
(375 μL)
|
|
|
|
|
2-8 °C
|
5 vial
(375 μL)
|
|
|
|
|
2-8 °C
|
5 vial
(375 μL)
|
|
|
|
|
2-8 °C
|
5 vial
(375 μL)
|
|
|
|
|
2-8 °C
|
5 vial
(375 μL)
|
|
|
|
|
2-8 °C
|
5 vial
(375 μL)
|
|
|
|
|
2-8 °C
|
5 vial
(375 μL)
|
|
|
|
Cytokine Panel 1 (human) Plate
|
2-8 °C
|
25 each
(1 each)
|
|
|
|
Diluent Assembly 4 (includes Diluent 3 - 25 mL, and Diluent 43 - 50 mL)
|
≤-10 °C
|
5 each
|
|
|
|
|
RT
|
5 bottle
(50 mL)
|
|
|
|
Product Inserts
|
|
|
|
Certificate of analysis
|
|
View More
|
|
SDS
|
|
|
|
Scientific Posters
|
|
|
|
Title
|
Journal
|
Year
|
|
Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection
|
|
|
|
Anti-SARS-CoV-2 IgG from severely ill COVID-19 patients promotes macrophage hyper-inflammatory responses
|
|
|
|
Reliability of self-sampling for accurate assessment of respiratory virus viral and immunologic kinetics
|
|
|
|
Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease-associated psychological morbidity
|
|
|
|
Early and late effects of maternal experience on hippocampal neurogenesis, microglia, and the circulating cytokine milieu
|
|
|
|
|
View All
|
Order Details
back
K15050D
Catalog No
Size
Price in USD
Qty
K15050D-1
1 plate size
$2,426.00
K15050D-2
5 plate size
$9,998.00
K15050D-4
25 plate size
$44,989.00
Meso Scale Japan 株式会社